<code id='E0F6C7D941'></code><style id='E0F6C7D941'></style>
    • <acronym id='E0F6C7D941'></acronym>
      <center id='E0F6C7D941'><center id='E0F6C7D941'><tfoot id='E0F6C7D941'></tfoot></center><abbr id='E0F6C7D941'><dir id='E0F6C7D941'><tfoot id='E0F6C7D941'></tfoot><noframes id='E0F6C7D941'>

    • <optgroup id='E0F6C7D941'><strike id='E0F6C7D941'><sup id='E0F6C7D941'></sup></strike><code id='E0F6C7D941'></code></optgroup>
        1. <b id='E0F6C7D941'><label id='E0F6C7D941'><select id='E0F6C7D941'><dt id='E0F6C7D941'><span id='E0F6C7D941'></span></dt></select></label></b><u id='E0F6C7D941'></u>
          <i id='E0F6C7D941'><strike id='E0F6C7D941'><tt id='E0F6C7D941'><pre id='E0F6C7D941'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:33
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          HHS's proposed rule does nothing to address the climate crisis
          HHS's proposed rule does nothing to address the climate crisis

          MariamZuhaib/APInApril,theU.S.DepartmentofHealthandHumanServices,theworld’smostpowerfulhealthcareage

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Does good food count as health care? Study aims to find out

          DianeWoodfordunpacksadeliveryfromCommunityServingsinherkitcheninBoston.Eachdeliverycontainsfivedays'